742
Participants
Start Date
October 31, 2006
Primary Completion Date
December 31, 2015
Study Completion Date
December 31, 2015
Teriflunomide (HMR1726)
Tablet, oral administration QD.
Investigational Site Number 1601, Vienna
Investigational Site Number 1602, Vienna
Investigational Site Number 4801, Glostrup Municipality
Investigational Site Number 3604, Tønsberg
Investigational Site Number 1802, Basel
Investigational Site Number 1604, Innsbruck
Investigational Site Number 4804, Sønderborg
Investigational Site Number 4802, Vejle
Investigational Site Number 1603, Graz
Investigational Site Number 1502, Tallinn
Investigational Site Number 2011, Berlin
Investigational Site Number 2409, Marseille
Investigational Site Number 2001, Berlin
Investigational Site Number 2009, Rostock
Investigational Site Number 1037, Allentown
Investigational Site Number 2808, Milan
Investigational Site Number 2202, Turku
Investigational Site Number 3507, Vinnitsa
Investigational Site Number 2814, Gallarate
Investigational Site Number 2408, Dijon
Investigational Site Number 2415, Besançon
Investigational Site Number 2809, Pavia
Investigational Site Number 2206, Pori
Investigational Site Number 2007, Hanover
Investigational Site Number 2411, Toulouse
Investigational Site Number 1032, Maitland
Investigational Site Number 2201, Tampere
Investigational Site Number 2402, Montpellier
Investigational Site Number 2406, Rennes
Investigational Site Number 2812, Padua
Investigational Site Number 5003, Izmir
Investigational Site Number 5006, Izmir
Investigational Site Number 2005, Giessen
Investigational Site Number 5005, Kocaeli
Investigational Site Number 2827, Fidenza
Investigational Site Number 2414, Nantes
Investigational Site Number 2000, Bochum
Investigational Site Number 2004, Essen
Investigational Site Number 2008, Münster
Investigational Site Number 1033, Detroit
Investigational Site Number 3504, Dnipropetrovsk
Investigational Site Number 2803, Florence
Investigational Site Number 1501, Tartu
Investigational Site Number 2405, Nancy
Investigational Site Number 2413, Lille
Investigational Site Number 3506, Kharkiv
Investigational Site Number 3510, Kharkiv
Investigational Site Number 2403, Clermont-Ferrand
Investigational Site Number 2010, Offenbach
Investigational Site Number 1038, Fort Wayne
Investigational Site Number 2012, Erbach im Odenwald
Investigational Site Number 3502, Odesa
Investigational Site Number 2003, Wiesbaden
Investigational Site Number 2401, Lyon
Investigational Site Number 3501, Zaporizhzhya
Investigational Site Number 2819, Bari
Investigational Site Number 2410, Paris
Investigational Site Number 3505, Ivano-Frankivsk
Investigational Site Number 4101, Olomouc
Investigational Site Number 3508, Lviv
Investigational Site Number 2404, Limoges
Investigational Site Number 3509, Uzhhorod
Investigational Site Number 3203, Moscow
Investigational Site Number 3205, Moscow
Investigational Site Number 3201, Saint Petersburg
Investigational Site Number 3202, Saint Petersburg
Investigational Site Number 3206, Saint Petersburg
Investigational Site Number 3207, Nizhny Novgorod
Investigational Site Number 3208, Novosibirsk
Investigational Site Number 1208, Calgary
Investigational Site Number 1212, Gatineau
Investigational Site Number 1205, Greenfield Park
Investigational Site Number 1201, Halifax
Investigational Site Number 1206, London
Investigational Site Number 1203, Montreal
Investigational Site Number 1204, Ottawa
Investigational Site Number 1202, Québec
Investigational Site Number 1211, St. John's
Investigational Site Number 1209, Toronto
Investigational Site Number 1210, Vancouver
Investigational Site Number 1207, Winnipeg
Investigational Site Number 3804, Santiago
Investigational Site Number 3802, Santiago
Investigational Site Number 3803, Santiago
Investigational Site Number 3801, Santiago
Investigational Site Number 3805, Viña del Mar
Investigational Site Number 2203, Helsinki
Investigational Site Number 2407, Nice
Investigational Site Number 2813, Roma
Investigational Site Number 2824, Roma
Investigational Site Number 4602, 's-Hertogenbosch
Investigational Site Number 4605, Breda
Investigational Site Number 4601, Nijmegen
Investigational Site Number 4604, Sittard-Geleen
Investigational Site Number 3601, Oslo
Investigational Site Number 3008, Bialystok
Investigational Site Number 3009, Bialystok
Investigational Site Number 3007, Gdansk
Investigational Site Number 3005, Lodz
Investigational Site Number 3006, Lublin
Investigational Site Number 3004, Lublin
Investigational Site Number 3001, Poznan
Investigational Site Number 3002, Warsaw
Investigational Site Number 3003, Warsaw
Investigational Site Number 4201, Coimbra
Investigational Site Number 4203, Lisbon
Investigational Site Number 3401, Stockholm
Investigational Site Number 5001, Sihhiye / Ankara
Investigational Site Number 2604, Dundee
Investigational Site Number 2607, London
Investigational Site Number 2608, London
Investigational Site Number 2600, Newcastle upon Tyne
Investigational Site Number 2601, Nottingham
Investigational Site Number 2609, Plymouth
Investigational Site Number 2606, Sheffield
Investigational Site Number 2602, Stoke-on-Trent
Lead Sponsor
Sanofi
INDUSTRY